Value Genome
Value Genome LLC is dedicated to bridging the gap between medical innovation and patient access by providing specialized consulting services in patient advocacy, medical affairs, HEOR & RWE, and market access. Their mission is to be a partner in growth for biopharmaceutical companies, delivering tailored solutions that enhance product value, optimize market strategies, and improve patient outcomes. They employ a collaborative approach, leveraging expertise across regions and therapeutic areas to support product launches, reimbursement, and comprehensive patient care.
Industries
Nr. of Employees
small (1-50)
Value Genome
Needham, Massachusetts, United States, North America
Services
Design and execution of HEOR studies, real-world data analysis, and evidence generation to support reimbursement and regulatory needs.
Development of market access strategies, pricing optimization, and payer engagement plans informed by payer research and regional expertise.
Launch preparation and execution, medical information governance, KOL engagement, data generation (Phase IV), and scientific communications.
Support for patient organizations and collaboration with innovators to integrate patient perspectives into evidence generation, trial design, and access strategies.
Design and execution of HEOR studies, real-world data analysis, and evidence generation to support reimbursement and regulatory needs.
Development of market access strategies, pricing optimization, and payer engagement plans informed by payer research and regional expertise.
Launch preparation and execution, medical information governance, KOL engagement, data generation (Phase IV), and scientific communications.
Support for patient organizations and collaboration with innovators to integrate patient perspectives into evidence generation, trial design, and access strategies.
Expertise Areas
- Health economics & outcomes research (HEOR)
- Real-world evidence (RWE) and observational research
- Market access strategy and pricing
- Medical affairs and launch readiness
Key Technologies
- Real-world evidence (RWE) analytics
- Health economic modeling
- Observational study design
- Registry and database management
News & Updates
Strategic Business Operations Analysis
Analysis and strategic planning for an oncology biopharmaceutical company's expansion and partnership in Southeast Asia.
Client Success Stories
Various case studies showcasing the company's work in transforming medical affairs, launching products, and expanding operations.
Beta-Thalassemia Real-World Analysis
Gathering data to understand the clinical and economic burden of Beta-Thalassemia.
Strategic Business Operations Analysis
Analysis and strategic planning for an oncology biopharmaceutical company's expansion and partnership in Southeast Asia.
Client Success Stories
Various case studies showcasing the company's work in transforming medical affairs, launching products, and expanding operations.
Beta-Thalassemia Real-World Analysis
Gathering data to understand the clinical and economic burden of Beta-Thalassemia.